Claim/exemption information - Registry number 3510336

Case number
2023-017879
Claimant name
Kurita America Inc.
Product identifier
RoCide™ DB20
Claim type
Original
Date of filing
Non-compliance(s) identified on SDS and/or label
Yes, Order issued
SDS and/or label compliance review decision date
Claim/exemption status
Cancelled
Date of claim/exemption status

Additional information

Date of the order
Order status
Unresolved

List of suggested corrective measures

  • Disclose either the name of the symbol or the symbol itself for each of the applicable product hazard classifications, specifically “skull and crossbones”.

  • Disclose the additional hazard classifications for the product (see appendix 1).

  • Disclose the correct date of decision granting the exemption, and clearly link which ingredients and concentrations are part of the subject of the claim for exemption under the HMIRA.

  • Disclose the hazard statements for each of the product hazard classification categories or subcategories (see appendix 2).

  • Disclose the information on personal protective equipment in section 6 of the SDS.

  • Disclose the precautionary statements for each of the product hazard classification categories or subcategories (see appendix 2).

  • Disclose the product oral, dermal and inhalation acute toxicity estimates (ATEs) of 837 mg/kg (0% unknown), 420 mg/kg (5% unknown) and 0.32 mg/L (70% unknown), respectively (see appendix 5).

  • Disclose the relevant conditions for safe storage (see appendix 4).

  • Disclose the relevant first-aid measures for inhalation and skin contact (see appendix 3).

  • Disclose the relevant precautions for safe handling (see appendix 4).

  • Remove all forward slashes or diagonal marks in the hazard classifications for which a choice is to be made.

Date modified: